Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
Mol Cancer. 2024 Jan 16;23(1):17. doi: 10.1186/s12943-023-01921-9.
Mol Cancer. 2024.
PMID: 38229082
Free PMC article.
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin.
Granit A, Mishra K, Barasch D, Peretz-Yablonsky T, Eyal S, Kakhlon O.
Granit A, et al. Among authors: peretz yablonsky t.
Front Cell Dev Biol. 2022 Dec 5;10:1014798. doi: 10.3389/fcell.2022.1014798. eCollection 2022.
Front Cell Dev Biol. 2022.
PMID: 36544904
Free PMC article.
Item in Clipboard
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance.
Alkhatib H, Rubinstein AM, Vasudevan S, Flashner-Abramson E, Stefansky S, Chowdhury SR, Oguche S, Peretz-Yablonsky T, Granit A, Granot Z, Ben-Porath I, Sheva K, Feldman J, Cohen NE, Meirovitz A, Kravchenko-Balasha N.
Alkhatib H, et al. Among authors: peretz yablonsky t.
Genome Med. 2022 Oct 20;14(1):120. doi: 10.1186/s13073-022-01121-y.
Genome Med. 2022.
PMID: 36266692
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.